Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 02 - 16 crawled time : 12:03 save search
ACCIONA and Plug Power to Partner on Establishing Leading Green Hydrogen Platform for Iberia
Published: 2021-02-16 (Crawled : 12:03) - globenewswire.com
PLUG | $2.49 -3.11% -3.21% 22M
|
Electronic Technology
|
| O: 2.88%
H: 0.0%
C: -9.24%
hydrogen platform
XPO Logistics Awarded LTL Collaborator of the Year by GlobalTranz
Published: 2021-02-16 (Crawled : 12:03) - globenewswire.com
XPO | $116.1 1.41% 1.64% 850K
|
Transportation
|
| O: 1.6%
H: 1.41%
C: -0.45%
collaboration awards
Shockwave Intravascular Lithotripsy FDA Approved to Treat Advanced Heart Disease
Published: 2021-02-16 (Crawled : 12:03) - globenewswire.com
SWAV | $328.6 -0.12% -0.1% 540K
|
Health Technology
|
| O: 4.83%
H: 0.04%
C: -6.18%
disease fda heart disease heart approval fda approval
HOOKIPA Pharma to Participate in Upcoming SVB Leerink Global Healthcare Conference
Published: 2021-02-16 (Crawled : 12:03) - globenewswire.com
HOOK | $0.707 -3.55% -2.88% 870K
|
Health Technology
|
| O: 4.85%
H: 4.3%
C: 2.64%
svb leerink global pharma
Baudax Bio Reports 2020 Annual Financial Results
Published: 2021-02-16 (Crawled : 12:03) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -1.57%
H: 4.26%
C: -5.85%
financial results results report
Freeline Announces Expansion of Executive Leadership
Published: 2021-02-16 (Crawled : 12:03) - globenewswire.com
FRLN | $6.48 0.0% 0
|
Health Technology
|
| O: 2.83%
H: 1.25%
C: -1.25%
expansion
Clene Nanomedicine Initiates Phase 2 Study of CNM-ZnAg for Patients with COVID-19
Published: 2021-02-16 (Crawled : 12:03) - globenewswire.com
CLNN S | $0.333 -4.64% -5.18% 550K
|
|
| O: 0.56%
H: 31.37%
C: 29.78%
covid phase 2 covid-19
Sio Gene Therapies to Present at the 10th Annual SVB Leerink Global Healthcare Conference
Published: 2021-02-16 (Crawled : 12:03) - globenewswire.com
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: 0.3%
H: 3.92%
C: -0.6%
gene therapies svb leerink global therapy gene therapy
Neuronetics to Report Fourth Quarter and Fiscal Year 2020 Financial and Operating Results and Host Conference Call
Published: 2021-02-16 (Crawled : 12:03) - globenewswire.com
STIM | $3.74 -1.58% -1.06% 55K
|
Health Technology
|
| O: 2.0%
H: 11.26%
C: 1.22%
results
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
MTTR | News M | $4.8 175.86% 63.6% 71M
|
AGBA | $2.5 100.0% 56.6% 200M
|
Finance
MLEC | $2.47 76.43% 42.62% 78M
|
n/a
NUWE | $0.334 29.96% 40.99% 2.5M
|
Manufacturing
EDBL | News | $6.26 66.49% 40.13% 16M
|
ATGL | $2.86 46.25% 32.8% 180K
|
ONFO | $0.6088 38.68% 27.74% 7.3M
|
n/a
VIVK | $1.43 33.65% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.7M
|
SDIG A | $3.64 35.32% 26.0% 990K
|
Your saved searches
Save your searches and get alerts when important news are released.